0001708138-21-000026.txt : 20210623 0001708138-21-000026.hdr.sgml : 20210623 20210623160245 ACCESSION NUMBER: 0001708138-21-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210621 FILED AS OF DATE: 20210623 DATE AS OF CHANGE: 20210623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YANCOPOULOS GEORGE CENTRAL INDEX KEY: 0001226690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211038740 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-06-21 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001226690 YANCOPOULOS GEORGE 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President and Chief Scientific Common Stock 2021-01-12 5 G 0 82108 0.0 A 82108 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 738 532.89 D 81370 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 7494 533.66 D 73876 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 8236 534.48 D 65640 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 4154 535.63 D 61486 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 3768 536.37 D 57718 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 6636 537.61 D 51082 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 4868 538.54 D 46214 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 3306 539.66 D 42908 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 8099 540.61 D 34809 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 19911 541.44 D 14898 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 10514 542.43 D 4384 I By Trust for Chldn. Common Stock 2021-06-21 4 S 0 2276 543.13 D 2108 I By Trust for Chldn. Common Stock 987483 D Common Stock 5845 I By 401(k) Plan Common Stock 211585 I by 2019 GRAT Class A Stock 2021-04-15 4 G 0 14000 0.0 A Common Stock 14000 14000 I By Tr. for Daughter Class A Stock 2021-04-15 4 G 0 14000 0.0 D Common Stock 14000 0 I by Daughter Class A Stock 2021-04-15 4 G 0 5383 0.0 D Common Stock 5383 0 I by Son Class A Stock 2021-04-15 4 G 0 5383 0.0 A Common Stock 5383 5383 I by Trust for Son As investment trustee of trusts for the benefit of the reporting person's children. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price. Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder. These shares of Class A Stock are presently convertible and such conversion feature does not expire. These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee. These shares of Class A Stock were held in custody for the benefit of the reporting person's child. /s/**George D. Yancopoulos 2021-06-23